FOXO4-DRI Regulatory Status As of June 2026, FOXO4-DRI is not approved by the FDA or any other regulatory agency for human use
Legge DN, Collard TJ,Stanko E, Hoskin AJ,Holt AK,Bull CJ,Kollareddy M, Bellamy J, Groves S
Numerous skin aging treatments exist, and mostly consist of topical products (e.g., retinoids, -hydroxyacids, broad-spectrum sunscreens, and antioxidant/anti-inflammatory agents, such as preparations containing vitamin C, vitamin E, and niacinamide6) and invasive or minimally invasive procedures (e.g., ablative and nonablative laser therapy, intense pulsed light therapy, radiofrequency, dermabrasion, and chemical peels)
Adamax 10mg Adamax, a potent synthetic peptide analog of Semax developed by Russian researchers, is primarily known for its: neuroprotective and cognitive-enhancing benefits